Drug created from genetically engineered goats

updated 10:54 a.m. ET Jan. 7, 2009

WASHINGTON - In a scientific first, an anti-clotting drug made from the milk of genetically engineered goats is moving closer to government approval for humans.

An evaluation by the Food and Drug Administration released Wednesday says the medication works and its safety is acceptable.

Called ATryn, the drug is intended to help people with a rare hereditary disorder that makes them vulnerable to life-threatening blood clots.

Its approval would be a major step toward new kinds of medications made not from chemicals, but from living organisms genetically manipulated by scientists. Similar drugs could be available in the next few years for a range of human ailments, including hemophilia.

ATryn is made by Massachusetts-based GTC Biotherapeutics.

Also in msnbc.com Health Your body's 10 weirdest health clues New blood test tells fetus gender at 5 weeks Ideal beauty is only a matter of millimeters Sleep better — look younger Whiskey hangover worse than vodka, study says   Animal Tracks: Eye candy for animal lovers

MORE FROM MORE HEALTH NEWS

More Health News Section Front

U.S. expands efforts to regulate meds in water Virtual alert texts kin if you're sent to a hospital Largest-ever kidney swap donors, patients meet Study: 15,000 will die from CT scans done in 1 year New VA patients younger, more often women Wireless devices may read words in the brain Pregnant woman claims hospital ignored her U.S. needs to address vaccine safety, report says Power line pollutants pose health risks Promising treatment for adults with sickle cell More Health News Section Front   Add More Health News headlines to your news reader: